Announced Sat, 14 Feb · 15:03 IST

Demise of CS and Compliance Officer

Management Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-1.1%1-day move

₹0.91

prior close

₹0.91

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.0+1.1+1.1+1.1-1.1-2.2-2.2-3.3+0.0-3.3-52.7-52.7-53.8-56.0

Up moveDown movePending

AI summary

Supha Pharmachem Ltd has informed BSE about the untimely death of its Company Secretary and Compliance Officer, Mr. Kapil Goplani (ICSI Membership No. A51763), who passed away on 13th January 2026. The company became aware of the demise only on 14th February 2026, when informed by his family, as he had been on leave for the previous two months. Mr. Goplani had been serving as CS and Compliance Officer since 1st June 2025, and the company has stated it is in the process of appointing a replacement.

Likely market impact

This is a compassionate disclosure rather than a business-changing event. Investors should note that the company currently lacks a Compliance Officer, which is a regulatory requirement under SEBI's LODR rules, so timely appointment of a replacement will be important to avoid any compliance lapses. No direct impact on stock price or operations is expected from the disclosure itself.